{"data":[{"accessionNo":"0001104659-26-097209","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Paradigm BioCapital Advisors GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1553748,"percentOfClass":7.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0001104659-26-097209","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Paradigm BioCapital Advisors LP","reportingCik":null,"personType":"PN","sharesOwned":1553748,"percentOfClass":7.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0001104659-26-097209","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Senai Asefaw, M.D.","reportingCik":null,"personType":"IN","sharesOwned":1553748,"percentOfClass":7.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0001104659-26-097209","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Paradigm BioCapital International Fund Ltd.","reportingCik":null,"personType":"CO","sharesOwned":1362882,"percentOfClass":6.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0001274173-26-000208","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"ASSEMBLY BIOSCIENCES, INC.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"JANUS HENDERSON GROUP Ltd.","reportingCik":null,"personType":"HC","sharesOwned":1359514,"percentOfClass":6.9,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Wehrly, Mark C.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Management, L.L.C.","reportingCik":null,"personType":"IA,OO","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Gehani, Varun N.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Giauque, Nicolas","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Husen, Avner A.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Kim, David T.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Linn, Michael G.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Luo Patrick (Cheng)","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Roberts, Jr., Thomas G.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Saito Edric C.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Short Daniel S.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Spokes, Andrew J. M.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Warren, John R.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Dapice Joshua J.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Dreyfuss, Philip D.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Dunn Hannah E.","reportingCik":null,"personType":"HC,IN","sharesOwned":1604590,"percentOfClass":8.1,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Institutional Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Institutional Partners II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Institutional Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Four Crossings Institutional Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Offshore Investors II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital (AM) Investors, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital F5 Master I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Partners, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Institutional (GP) V, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon F5 (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000380","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-04","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0001123292-26-000750","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001426800","issuerName":"ASSEMBLY BIOSCIENCES, INC.","ticker":"ASMB","cusip":"045396108","securityClass":"Common Stock, par value $0.001","eventDate":"2026-05-22","reportingPerson":"GILEAD SCIENCES, INC.","reportingCik":"0000882095","personType":"CO","sharesOwned":4977089,"percentOfClass":25.1,"filedAt":"2026-05-27","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0001104659-26-058623","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-05-04","reportingPerson":"Paradigm BioCapital Advisors LP","reportingCik":null,"personType":"PN","sharesOwned":865251,"percentOfClass":5.4,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0001104659-26-058623","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-05-04","reportingPerson":"Paradigm BioCapital Advisors GP LLC","reportingCik":null,"personType":"OO","sharesOwned":865251,"percentOfClass":5.4,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0001104659-26-058623","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-05-04","reportingPerson":"Senai Asefaw, M.D.","reportingCik":null,"personType":"IN","sharesOwned":865251,"percentOfClass":5.4,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0001104659-26-058623","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":"045396207","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-05-04","reportingPerson":"Paradigm BioCapital International Fund Ltd.","reportingCik":null,"personType":"CO","sharesOwned":758963,"percentOfClass":4.8,"filedAt":"2026-05-11","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Wehrly, Mark C.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Dapice Joshua J.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Dreyfuss, Philip D.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Dunn Hannah E.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Gehani, Varun N.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Giauque, Nicolas","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Husen, Avner A.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Kim, David T.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Linn, Michael G.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Luo Patrick (Cheng)","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Roberts, Jr., Thomas G.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Saito Edric C.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Short Daniel S.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Spokes, Andrew J. M.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Warren, John R.","reportingCik":null,"personType":"IN","sharesOwned":1227590,"percentOfClass":7.8,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Partners, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":1175592,"percentOfClass":7.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Offshore Investors II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":497192,"percentOfClass":3.1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":239462,"percentOfClass":1.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Institutional Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":224245,"percentOfClass":1.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Institutional Partners II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":75077,"percentOfClass":0.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Institutional (GP) V, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":58135,"percentOfClass":0.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Four Crossings Institutional Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":58135,"percentOfClass":0.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon F5 (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":51998,"percentOfClass":0.3,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital F5 Master I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":51998,"percentOfClass":0.3,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Institutional Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":48548,"percentOfClass":0.3,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital (AM) Investors, L.P.","reportingCik":null,"personType":"PN","sharesOwned":32933,"percentOfClass":0.2,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Patel, Rajiv A.","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Seybold, William","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0000908834-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001426800","issuerName":"Assembly Biosciences, Inc.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock, par value $0.001 per shares (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Fried, Richard B","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"},{"accessionNo":"0001274173-25-000331","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001426800","issuerName":"ASSEMBLY BIOSCIENCES, INC.","ticker":"ASMB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-11-28","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":1341508,"percentOfClass":8.2,"filedAt":"2025-12-08","canonicalUrl":"https://xoomar.com/markets/stocks/asmb"}],"updatedAt":"2026-11-03T19:26:35.183Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/asmb","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}